Online information about mammography screening in Italy from 2014 to 2021
- PMID: 35477449
- PMCID: PMC9044849
- DOI: 10.1186/s12905-022-01718-w
Online information about mammography screening in Italy from 2014 to 2021
Abstract
Background: Many studies have reported that the information women receive about the risk-to-benefit ratio of breast cancer screening is still scarce and biased toward benefit. In a study we conducted in 2014, we analysed online documents about breast cancer screening that were addressed to the general female public. In the present study, we used the same methodology to verify if the information provided to women was improved.
Methods: We evaluated documents addressed to the general female public and posted on the Internet by the Italian national and regional public health services. False-positive and false-negative screening results, biopsy-proven false-positive results, interval cancer, overdiagnosis, radiation exposure, and decrease in risk of mortality were analysed. In addition, quantitative data were searched.
Results: In 2021, the most frequently reported information was reduction in breast cancer mortality (58.2%). The most frequently reported risk was a false-positive mammogram (42.5%). Similar frequency rates were reported for interval cancer, false-negative result, and radiation exposure (35.8%, 31.3%, and 28.3%, respectively). Overdiagnosis and biopsy-proven false-positive result were the less reported risks (20.1% and 10.4%). Thirteen documents provided quantitative data about reduction of mortality risk (16.7%), and only 19 provided quantitative data about risks or harms (8.4%). Almost all organisations sent letters of invitation to women (92.5%) and provided screening free of charge (92.5%). The most recommended was biennial screening for women aged between 50 and 69 years (48.5%). Compared with the information in 2014, that in 2021 showed some improvements. The most marked improvements were in the numbers of reports on overdiagnosis, which increased from 8.0 to 20.1%, and biopsy-proven false-positive result, which increased from 1.4 to 10.4%. Regarding the benefits of breast cancer screening, reduced mortality risk became increasingly reported from 2014 (34.5%) to 2021 (58.2%). Conversely, quantitative data remained scarce in 2021.
Conclusions: Moderate improvements in information were observed from 2014 to 2021. However, the information on breast cancer screening in documents intended for women published on Italian websites remain scarce.
Keywords: Breast cancer prevention; Information; Mammography; Website.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Scarce information about breast cancer screening: An Italian websites analysis.Medicine (Baltimore). 2016 Dec;95(50):e5615. doi: 10.1097/MD.0000000000005615. Medicine (Baltimore). 2016. PMID: 27977602 Free PMC article.
-
[Tailored Breast Screening Trial (TBST)].Epidemiol Prev. 2013 Jul-Oct;37(4-5):317-27. Epidemiol Prev. 2013. PMID: 24293498 Clinical Trial. Italian.
-
[Content of official addressed to women informative documents about breast cancer screening in Spain].Rev Esp Salud Publica. 2018 Oct 29;92:e201810076. Rev Esp Salud Publica. 2018. PMID: 30361472 Free PMC article. Spanish.
-
Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).Br J Cancer. 2022 Mar;126(4):673-688. doi: 10.1038/s41416-021-01521-8. Epub 2021 Nov 26. Br J Cancer. 2022. PMID: 34837076 Free PMC article.
-
Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.CMAJ. 2001 Feb 20;164(4):469-76. CMAJ. 2001. PMID: 11233866 Free PMC article. Review.
Cited by
-
Do health professionals know about overdiagnosis in screening, and how are they dealing with it? A mixed-methods systematic scoping review.PLoS One. 2025 Feb 3;20(2):e0315247. doi: 10.1371/journal.pone.0315247. eCollection 2025. PLoS One. 2025. PMID: 39899650 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical